Please login to the form below

Not currently logged in

The most viewed healthcare terms

The terms and definitions that have received the most views since we launched the PMliVE Glossary.

  • Affiliate marketing
    A form of marketing or advertising used on the internet. Companies that sell products or services online link to relevant sites. The advertising on the other or 'affiliate' sites is paid for according to results
  • Prescription Medicines Code of Practice Authority (PMCPA)
    Administers the ABPI Code of Practice independently of the ABPI in the UK. The code covers the promotion of medicines for prescribing to healthcare professionals and the provision of information to the public about prescription only medicines in the UK.
  • Four Ms
    Money, material, machine and manpower – the traditional framework for viewing the resources available to a business, which can be useful when designing a business plan
  • Market skimming pricing
    A method of pricing involving setting a high initial price for a product to attract buyers with suitable resources who also have a strong want for the product
  • United States adopted name (USAN)
    A designation for any compound used as a drug that is not protected as an intellectual property. This name is negotiated by the compound's manufacturers as well as a council sponsored jointly by the American Medical Association, American Pharmaceutical Association, and United States Pharmacopeial Convention
  • Clinical trial

    A clinical trial is a research study into a new therapies, vaccines or new ways of using known treatments to determine the safety and efficacy of a drug before it reaches the public. Clinical trials are also referred to as medical research or research studies.

    Trials are conducted in four phases with an increasing number of patients enrolled at each phase:
    Phase I – involves a small number of participants and tests the actions of the drug in humans
    Phase II – evaluates the drug for a particular indicated use
    Phase III – gathers additional evidence on a drug once preliminary effectiveness has been proved
    Phase IV – ongoing research after the drug has gone to market

  • Opportunities to hear (OTH)
    The number of chances a listener will get to hear an advertisment
  • Sensitive data
    Personal information of individuals, including racial or ethnic origin, political opinions, religious beliefs and health
  • Data collection
    The process of collecting market research data accomplished through interviewing or surveying
  • Infiltration marketing
    A marketing strategy aimed at infiltrating consumers at a local level, targeting the communities and communications of potential trend setters. This can include a marketer’s use of social media or online forums to engage with customers about a product or service
  • Relative advantage
    A product's degree of superiority and attractiveness to customers over similar existing products
  • Cost-effectiveness (in media/advertising)
    A measure of media effectiveness based on a comparison of potential or actual audience and the cost for placement, usually expressed as cost-per-thousand persons viewing
    A framework for viewing the macro environment involving the elements: political, economic, environmental, socio-cultural and technological
  • Utility (pharmacoeconomics)
    A measure of relative satisfaction. In healthcare and pharma this can be the value of an outcome based on the perception of how likely that outcome will happen
  • Open observation
    An instance in market research where people know they are being studied by observers
  • Pharmaceutical Pricing Regulation Scheme (PPRS)
    The prices of branded medicines in the NHS are controlled by the Pharmaceutical Price Regulation Scheme (PPRS) negotiated by the UK government with the Association of the British Pharmaceutical Industry (ABPI), as the representative body for those companies supplying the NHS with medicines
  • Blind (clinical trial terms)
    A clinical trial is "blind" if participants are unaware of whether they are in the experimental or control arm of the study; also referred to as masked
  • Business to consumer (B2C)
    Relating to the sale of a product for personal consumption. The buyer may be an individual, family or other group, buying to use the product themselves, or for end use by another individual
  • Boston matrix
    A product portfolio evaluation tool developed by the Boston Consulting Group, the matrix categorises products into one of four classifications based on market growth and market share. 

    The four classifications are:

    Cash cow – low growth, high market share
    Star – high growth, high market share
    Problem child – high growth, low market share
    Dog – low growth, low market share
  • Off-label use
    A healthcare professional approving a drug for a condition for which it is not approved by the necessary regulatory body

Featured jobs

Subscribe to our email news alerts


Add my company
KnowledgePoint360 Group

KnowledgePoint360's medical communications expertise helps healthcare providers improve patient care, and helps pharma and biotech companies inform clinicians about important...